Key result
Apical HCM is linked to universal apical perfusion defects on CMR vs asymmetrical septal HCM.
Why the study?
Microvascular dysfunction is well described in hypertrophic cardiomyopathy, leading researchers to hypothesize that apical perfusion defects would be common in apical hypertrophic cardiomyopathy.
Does apical hypertrophic cardiomyopathy feature ubiquitous apical ischemia compared to other forms of HCM and healthy volunteers?
Observational (n=190)
Yes
Does apical hypertrophic cardiomyopathy feature ubiquitous apical ischemia compared to other forms of HCM and healthy volunteers?
Apical microvascular ischemia is a universal, disease-defining feature of both mild and advanced apical hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Apical ischemia may define ApHCM; hypothesis-generating for its prognostic role and therapeutic targeting.
Background: Apical hypertrophic cardiomyopathy (ApHCM) accounts for ≈10% of hypertrophic cardiomyopathy cases and is characterized by apical hypertrophy, apical cavity obliteration, and tall ECG R waves with ischemic-looking deep T-wave inversion. These may be present even with <15 mm apical hypertrophy (relative ApHCM). Microvascular dysfunction is well described in hypertrophic cardiomyopathy. We hypothesized that apical perfusion defects would be common in ApHCM. Methods: A 2-center study using cardiovascular magnetic resonance short- and long-axis quantitative adenosine vasodilator stress perfusion mapping. One hundred patients with ApHCM (68 overt hypertrophy [≥15 mm] and 32 relative ApHCM) were compared with 50 patients with asymmetrical septal hypertrophy hypertrophic cardiomyopathy and 40 healthy volunteer controls. Perfusion was assessed visually and quantitatively as myocardial blood flow and myocardial perfusion reserve. Results: Apical perfusion defects were present in all overt ApHCM patients (100%), all relative ApHCM patients (100%), 36% of asymmetrical septal hypertrophy hypertrophic cardiomyopathy, and 0% of healthy volunteers ( P <0.001). In 10% of patients with ApHCM, perfusion defects were sufficiently apical that conventional short-axis views missed them. In 29%, stress myocardial blood flow fell below rest values. Stress myocardial blood flow was most impaired subendocardially, with greater hypertrophy or scar, and with apical aneurysms. Impaired apical myocardial blood flow was most strongly predicted by thicker apical segments (β-coefficient, −0.031 mL/g per min [CI, −0.06 to −0.01]; P =0.013), higher ejection fraction (−0.025 mL/g per min [CI, −0.04 to −0.01]; P <0.005), and ECG maximum R-wave height (−0.023 mL/g per min [CI, −0.04 to −0.01]; P <0.005). Conclusions: Apical perfusion defects are universally present in ApHCM at all stages. Its ubiquitous presence along with characteristic ECG suggests ischemia may play a disease-defining role in ApHCM.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2023) conducted an observational in Apical hypertrophic cardiomyopathy (n=190). Apical hypertrophic cardiomyopathy vs. Asymmetrical septal hypertrophy hypertrophic cardiomyopathy and healthy volunteers was evaluated on Presence of apical perfusion defects assessed by CMR stress perfusion mapping (p=<0.001). Apical perfusion defects were present in 100% of patients with overt and relative apical hypertrophic cardiomyopathy, compared to 36% of patients with asymmetrical septal hypertrophy and 0% of healthy volunteers.
Synapse has enriched 10 related papers. Consider them for comparative context: